Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics (NASDAQ: KYMR) notched an almost 23% share ...

Although only tested in rats thus far, the polymer-based treatment could repair tissue that are impacted in a variety of ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

If generative AI could contribute in the slightest to such discoveries—as has been promised since the start of the AI ...

With this level of control, scientists can fine-tune how nanomedicines interact with the human body. These new designs are ...

Scientists have developed a powerful new injectable treatment that, when administered after a heart attack, helps the heart ...

Aclaris Therapeutics, Inc.’s ACRS share price has surged by 6.72%, which has investors questioning if this is right time to sell.